R. Andrew Eckert
Andy Eckert has held a number of senior executive positions during his career. Prior to joining Acelity, he served as Chief Executive Officer of Valence Health, an emerging leader in value-based healthcare. He previously served as Chief Executive Officer of TriZetto, a leader in payer information technology, and as Chairman and Chief Executive Officer of CRC Health Group, the leading behavioral health treatment provider owned by Bain Capital. Earlier in his career, Mr. Eckert was Chief Executive Officer of Eclipsys Corporation from 2005-2009, and Chief Executive Officer of SumTotal Systems from 2002-2005. He began his career at ADAC Laboratories, including four years as Chairman and Chief Executive Officer until its sale to Philips Medical systems in 2000.
Mr. Eckert has served on a number of corporate boards and is currently the Chairman of Varian Medical Systems, as well as a Director at Becton, Dickinson and Company. He has a Bachelor of Science in Industrial Engineering and a Master of Business Administration, both from Stanford University.
Mr. Agarwal has nearly 20 years of global business management experience in the healthcare industry. Prior to joining Acelity in 2014, he served as President, Orthopedic Reconstruction for the Advanced Surgical Devices Division at Smith & Nephew. His past roles have also included Chief Operating Officer and Senior Vice President for the Advanced Surgical Devices Division at Smith & Nephew, and various leadership positions within GE Healthcare.
Cindy Beaulieu is a seasoned global executive, experienced in building cross-functional, cross-cultural and high-performing teams to drive organizational transformations. Prior to joining Acelity, Mrs. Beaulieu most recently served as the Senior Vice President Strategic Operations at One Call Care Management. She has also held several strategic operations and leadership positions with Staples, Inc. and was a Partner at Information Services Group (ISG). Her experience extends across industries, including technology, healthcare, retail, manufacturing, consulting and outsourcing. She holds a Master of Business Administration from Duke University and a Bachelor of Science in Business Administration from Westfield State College.
Mr. Bajaj joined Acelity in 2009 and has served in various leadership roles at Acelity since then. In addition to his responsibilities of leading Strategy and Business Development, he also leads Digital Wound Care Franchise for the Company. Prior to joining Acelity, Mr. Bajaj served at JPMorgan’s Investment Banking Division in New York from 2003 - 2009, most recently in the position of Vice President. From 1996 - 2001, Mr. Bajaj was at Arthur Andersen & Co in New Delhi, India, where he served as Senior Associate, Assurance and Business Advisory. He holds an MBA from Kellogg School of Management at Northwestern University and is a Chartered Accountant.
Mr. Bibb previously served as Associate General Counsel, Corporate, Securities, Mergers and Acquisitions before taking on his current role in 2011. He is also responsible for the Global Human Resources function. Prior to joining the company in 2003, Mr. Bibb practiced law at the law firms of Cox Smith Matthews Incorporated and Baker Botts, L.L.P.
Mr. Elwood’s work at Acelity spans more than a decade. Since joining the company, he has held global leadership roles across various parts of the supply chain, most recently as Vice President of Global Manufacturing. Prior to joining Acelity in 2007, Mr. Elwood held positions with Bose, Hewlett Packard and Celestica.
Teresa Johnson (TJ)
For more than a decade, Ms. Johnson has been an instrumental member of the Acelity team, most recently leading the Post-Acute franchise. She has held positions in Marketing, Sales, Operations and Finance, including serving as Interim CFO. In her current role, she also leads Quality & Regulatory services. Before joining Acelity, Ms. Johnson spent 14 years working for top public accounting firms, including Arthur Andersen LLP and Price Waterhouse LLP.
Tracy Jokinen joined the Company as Executive Vice President and Chief Financial Officer in June 2017. She is also responsible for the Compliance & Risk Management teams. From May 2014 to March 2017, Ms. Jokinen was Chief Financial Officer for G&K Services, Inc. Prior to that, Ms. Jokinen spent 22 years with Valspar Corporation, where she held various positions with increasing responsibility, most recently as Vice President, Corporate Finance and Strategy from 2013 to 2014, where she was responsible for Valspar’s Tax, Treasury, Investor Relations, Internal Audit, Operations Finance and Corporate Accounting functions. Prior to that role Ms. Jokinen held the position of Vice President, Corporate Controller and Chief Accounting Officer from 2008 to 2012, with responsibility for Valspar’s SEC reporting obligations and global financial control policies. Ms. Jokinen serves on the board of Alamo Group, where she is a member of the Audit Committee and Compensation Committee.
For nearly two decades, Mr. Kashyap has served in a number of leadership roles at Acelity, setting and leading growth strategies for commercial operations. Prior to assuming responsibility for all the Americas, he most recently served as President of North America. Before that, he served as Senior Vice President, Strategy and Business Development, and previously held leadership roles in strategic marketing and international commercial teams.
Mr. Kraemer has served in various capacities with Acelity for more than two decades, most recently as Vice President, Global Compliance. Before joining the compliance team in 2013, Mr. Kraemer spent more than 15 years as an in-house attorney, managing company litigation and providing strategic counsel to the company’s human resources, regulatory, quality, marketing and compliance functions.
Before joining the company in 2010, Dr. Silverman served as Chief of Plastic Surgery at the University of Maryland School of Medicine and continues to teach as an Associate Professor there. Previously, he held academic positions at John Hopkins School of Medicine, Harvard School of Medicine and served as Chief of Plastic Surgery at the Baltimore Veterans Administration Medical Center.
Mr. Subrahmanian has an extensive background in commercial leadership, working with some of the largest medical device and pharmaceutical companies in the world. He brings more than 25 years of leadership experience in business development, finance and commercial management from Merck, Sanofi-Aventis, Hoechst Marion Roussel LTD, and most recently, Stryker as Group President, International.